Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
暂无分享,去创建一个
P. Libby | N. Paynter | P. Ridker | R. Glynn | W. Koenig | P. Amarenco | M. Elam | W. Hiatt | B. Everett | S. Ishibashi | J. Fruchart | H. Ginsberg | A. Pradhan | Brendan M. Everett | B. Nordestgaard